Health and Healthcare

Thoratec's Hammering (THOR)

Thoratec_logoThoratec Corporation (NASDAQ: THOR) is having a rough morning.  The heart failure device company has a product recall it announced last Friday, and medical device recalls are not what the public likes to hear about.

Thoratec issued a worldwide medical device correction of all serialnumbers of the HeartMate II Left Ventricular Assist Systems havingCatalogue No. 1355 or 102139.  These have been distributed since thebeginning of clinical studies in November 2003.

The company said that over time, wear and fatigue of the percutaneouslead connecting the HeartMate II LVAS blood pump with the SystemController may result in damage that could interrupt pump function,require re-operation to replace the pump and potentially result inserious injury or death.

It also said that the estimated probability of the need for pumpreplacement due to percutaneous lead damage is 1.3% at 12 months, 6.5%at 24 months and 11.4% at 36 months.

There is just one small problem with recalls and product defects inmedical device companies.  Patients generally have to undergo a newsurgical procedure to have the recalled item removed and have to havenew devices inserted.  This is almost always done at the same time, butit isn’t quite the same as taking your car in because the windshieldwipers have a 15% failure rate.

The other issue about medical device recalls is that they can destroythe image medical device company which issued a recall.  Lastly, it canturn doctors away to competing products or encourage them to stop useof the recalled product even if the replacement is fine.  Few doctorslike to admit it, but they also have to respond and react to publicopinion or negative press.

Thoratec shares are down 14% at $21.53, and the 52-week trading rangeis $12.92 to $29.72.  The company is very lucky that this reactionisn’t worse.

Jon C. Ogg
October 27, 2008

Take Charge of Your Retirement In Just A Few Minutes (Sponsor)

Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s made it easier than ever for you to connect with a vetted financial advisor.

Here’s how it works:

  1. Answer a Few Simple Questions. Tell us a bit about your goals and preferences—it only takes a few minutes!
  2. Get Matched with Vetted Advisors Our smart tool matches you with up to three pre-screened, vetted advisors who serve your area and are held to a fiduciary standard to act in your best interests. Click here to begin
  3. Choose Your  Fit Review their profiles, schedule an introductory call (or meet in person), and select the advisor who feel is right for you.

Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!

 

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.